Completed
Ca_PulmonObservational Retrospective Study to Describe the Management of Advanced or Metastatic EGFR (Epidermal Growth Factor Receptor) Mutated Non-small Cell Lung Cancer Patients in Spain
What is being collected
Data Collection
Collected from past medical records and data - RetrospectiveWho is being recruted
Lung Diseases+4
+ Neoplasms
+ Neoplasms by Site
Over 18 Years
+5 Eligibility Criteria
How is the trial designed
Observational
Study Start: March 2013
Summary
Principal SponsorAstraZeneca
Last updated: October 30, 2013
Sourced from a government-validated database.Claim as a partner
Study start date: March 1, 2013
Actual date on which the first participant was enrolled.Observational retrospective study to describe the management of advanced or metastatic EGFR mutated non-small cell lung cancer patients in Spain
Principal SponsorAstraZeneca
Last updated: October 30, 2013
Sourced from a government-validated database.Claim as a partner
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.Design Details
187 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Conditions
Criteria
Any sex
Biological sex of participants that are eligible to enroll.Over 18 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Lung DiseasesNeoplasmsNeoplasms by SiteRespiratory Tract DiseasesRespiratory Tract NeoplasmsThoracic NeoplasmsLung Neoplasms
Criteria
3 inclusion criteria required to participate
Availability of medical record
Confirmed EGFR mutation by a validated test
Histologically or cytologically confirmed newly locally advanced or metastatic NSCLC (stage IIIB/IV)
2 exclusion criteria prevent from participating
Participating on a blinded randomized clinical trial at any time during the study period
Pregnant women (due to they do not reflect daily clinical practice)
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.Study Objectives
Study Objectives
Primary Objectives
Secondary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 12 locations
Research Site
Córdoba, SpainResearch Site
Donostia / San Sebastian, SpainResearch Site
Granada, SpainCompleted12 Study Centers